CRI, Ginger.io and Verizon Partner to Solve Healthcare’s Superutilizer Challenge
Centerstone Research Institute (CRI), Ginger.io and Verizon have combined their expertise in behavioral healthcare, analytics and mobile technology to launch a new program – coactionHealth – aimed at helping people with complex mental and physical health conditions better manage their health and significantly reduce healthcare costs.
“Five percent of high-utilizer Medicaid beneficiaries represent more than half of the state Medicaid dollars spent each year,” said Tom Doub, PhD, CEO of Centerstone Research Institute. “These individuals typically have co-occurring mental and physical disorders that make managing their care difficult. Understanding their needs and finding ways to help them better manage their health is critical in controlling healthcare costs.”
In April 2014, CRI, Ginger.io, Verizon and other partners began a three-month pilot of coactionHealth. coactionHealth is an intervention program for individuals with complex behavioral health disorders that promotes greater health and wellbeing through a high-touch, high-tech healthcare model. The pilot involved high Medicaid-utilizer patients—those with more than $25,000 in annual healthcare-related expenses—who also have co-occurring mental and physical health needs, including schizophrenia, bipolar disorder, personality disorders, heart disease, chronic obstructive pulmonary disorder (COPD) and diabetes. read more
CRI Names Russell Galyon as Chief Operating Officer
Centerstone Research Institute (CRI), a not-for-profit organization dedicated to improving behavioral healthcare through research and information technology, today announced Russell Galyon as the company’s chief operating officer. Galyon will head day-to-day operations to ensure CRI grows and maintains operational excellence.
“Russ has been vital to the success of CRI and has shown tremendous leadership throughout his tenure here,” said Tom Doub, PhD, CRI’s chief executive officer. “I’m confident he will thrive in this new role and will ensure CRI’s expertise in research and technology will be leveraged to help solve some of healthcare’s greatest problems.” read more
CRI to Evaluate Tennessee Suicide Prevention Network
This year, Jennifer Lockman, Program Evaluator for Centerstone Research Institute, will conduct an evaluation project examining Tennessee Suicide Prevention Network (TSPN). Specifically, Lockman, in conjunction with Kathryn Mathes, VP for Evaluation and Research, will define the science and best practices behind successful suicide prevention coalitions. read more
Kathryn Sielbeck-Mathes and Rebecca Selove, co-author “Feminist Evaluation and Research: Theory and Practice”
In their article, based on three evaluations of substance abuse treatment programs for individuals with co-occurring mental illness and substance abuse issues, co-authors Kathryn Sielbeck-Mathes and Rebecca Selove, discuss the importance of framing and shared understanding between evaluators and evaluation stakeholders. Their lessons learned were featured on the American Evaluation Association website. read more
CRI Showcases Enlighten Analytics at Health Datapalooza
CRI demoed its Enlighten Analytics platform at Health Datapalooza in Washington, DC, this month. Health Datapalooza is an annual national conference that brings together companies, startups, academics, government agencies and individuals with the newest and most innovative and effective uses of data to improve healthcare. read more
Groundbreaking Hepatitis C Screening Procedure
CRI and Centerstone recently partnered with the Indiana University (IU) School of Public Health-Bloomington to validate for the first time ever a behaviorally based screening method for Hepatitis C in an outpatient community mental healthcare setting.
The initiative, funded by a $14,000 grant from the IU School of Public Health-Bloomington, will be conducted in Bloomington in close collaboration with the Indiana State Department of Health and the Monroe County Health Department. The groundbreaking Hepatitis C testing and referral initiative is designed to identify and treat those with the viral disease before it advances and causes significant physical health problems. read more
Thomas W. Mahler Jr. Named Chair of CRI’s Board of Directors
Centerstone Research Institute (CRI), a not-for-profit organization dedicated to improving behavioral healthcare through research and information technology, today announced that Thomas W. Mahler Jr. has been named Chair of its Board of Directors. A member of CRI’s board since 2008, Mahler began his two-year term as Chair on January 29, 2014. The CRI Board of Directors provides strategic direction to the organization, helping to raise awareness of and securing funding to support its work. read more
In Review: Knowledge Network Summit
View highlights from the Spring 2014 Knowledge Network Summit.
CRI Helps Individuals with Serious Mental Illness Quit Smoking
David Ayer, PhD, director of clinical research, and other investigators with Massachusetts General Hospital and Harvard Medical School in Boston, conducted a randomized clinical trial that showed the antismoking drug varenicline (Chantix, Pfizer Inc) boosts quit rates in smokers with serious mental illness. The trial was conducted at 10 community mental health centers, including a Centerstone site in Indiana, in the United States. The study was led by Anne Eden Evins, MD, MPH, of Massachusetts General Hospital, and published in the January 8 issue of JAMA.